Crossmark

ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression

Crossref DOI link: https://doi.org/10.1186/s13046-018-0919-8

Published Online: 2018-10-30

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Cong

Ge, Chao

Liu, Zheng

Li, Liangyu

Zhao, Fangyu

Tian, Hua

Chen, Taoyang

Li, Hong

Yao, Ming

Li, Jinjun
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81773152, 81472726)

the National Key Sci-Tech Special Project of China (2018ZX10723204-006)

the SKLORG Research foundation (91-17-22)
License Information

Text and Data Mining valid from 2018-10-30
More Information

Article History

Received: 21 May 2018

Accepted: 27 September 2018

First Online: 30 October 2018

Ethics approval and consent to participate

: All animal procedures were performed under the guidelines of the Shanghai Medical Experimental Animal Care Commission. The study was approved by the Chinese Ethical Review Committee and signed informed consent was obtained from each patient.

: All the patients that involved in the study have given their consent to publish their individual data.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.